Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IDRYV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
LCB-67
|
|||||
| Synonyms |
Anti-DLK1 ADC; MMAE-anti-DLK1; PYX 202; DLK1-MMAE; LCB67; LCB 67; PAY-202; PAY202
Click to Show/Hide
|
|||||
| Organization |
LegoChem Biosciences, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 5 Indication(s)
Acute myeloid leukaemia [ICD11:2A60]
Clinical candidate
Hepatocellular carcinoma [ICD11:2C12]
Clinical candidate
Myelodysplastic syndrome [ICD11:2A37]
Clinical candidate
Neuroblastoma [ICD11:2A00]
Clinical candidate
Rhabdomyosarcoma [ICD11:2B55]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Protein delta homolog 1 (DLK1)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.